2019;9:e026573 Weintraub S, Dikmen SS, Heaton RK, Tulsky DS, Zelazo PD, Bauer PJ, et al
Ozempic Blindness Lawsuit Overview Ozempic blindness lawsuits claim that the drugs manufacturer, Novo Nordisk, failed to adequately warn consumers about the risk of vision loss caused by non-arteritic anterior ischemic optic neuropathy (NAION)
Some people notice appetite changes within the first few weeks, while visible weight loss often becomes more noticeable after a few months
Mechanisms of CVD and CKD in patients with diabetes Vascular damages of ASCVD in patients with diabetes are characterized by endothelial and vascular smooth muscle cell dysfunction [12]
More serious but rare risks can include pancreatitis, gallbladder issues, and thyroid C-cell tumors (in animal studies)